123 related articles for article (PubMed ID: 2711027)
1. Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.
Tokuma Y; Fujiwara T; Niwa T; Hashimoto T; Noguchi H
Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):249-62. PubMed ID: 2711027
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver.
Niwa T; Tokuma Y; Nakagawa K; Noguchi H
Drug Metab Dispos; 1989; 17(1):64-8. PubMed ID: 2566472
[TBL] [Abstract][Full Text] [Related]
3. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Tokuma Y; Fujiwara T; Noguchi H
Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
Tokuma Y; Fujiwara T; Noguchi H
Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
Teramura T; Watanabe T; Higuchi S; Hashimoto K
Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
[TBL] [Abstract][Full Text] [Related]
6. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
Cook CS; Karim A; Sollman P
Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
9. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
Jezequel SG; Uden S; Wastall P
Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
Bohlooli S; Keyhanfar F; Mahmoudian M
Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic study of benidipine hydrochloride in rats and dogs.
Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1750-3. PubMed ID: 3219154
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man.
Niwa T; Tokuma Y; Nakagawa K; Noguchi H; Yamazoe Y; Kato R
Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):161-72. PubMed ID: 3393731
[TBL] [Abstract][Full Text] [Related]
14. Effects of nilvadipine on the cardiovascular system in experimental animals.
Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of the enantiomers of verapamil in the dog.
Bai SA; Lankford SM; Johnson LM
Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
[TBL] [Abstract][Full Text] [Related]
16. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs.
Tokuma Y; Sekiguchi M; Niwa T; Noguchi H
Xenobiotica; 1988 Jan; 18(1):21-8. PubMed ID: 3354229
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
